Literature DB >> 3006486

Association of human T lymphotropic virus type III antibodies with sexual and other behaviors in a cohort of homosexual men from Boston with and without generalized lymphadenopathy.

K H Mayer, D Ayotte, J E Groopman, A M Stoddard, M Sarngadharan, R Gallo.   

Abstract

Forty asymptomatic homosexually active men seen at a Boston community health center and 39 men with generalized lymphadenopathy were interviewed and filled out detailed epidemiologic questionnaires. Twenty percent of the asymptomatic men and 92 percent of those with lymphadenopathy had antibodies to human T lymphotropic virus type III (HTLV-III). None of the men have subsequently had the acquired immune deficiency syndrome (AIDS). Seropositivity was associated with receptive anal intercourse and oral exposure to ejaculate, a history of hepatitis B, anal gonorrhea, or intestinal parasites, but no other sexually transmitted diseases, and did not correlate with the use of recreational drugs. More of the seropositive men had multiple partners from New York City. An association with seropositivity was less evident in relation to the numbers of partners from San Francisco or Los Angeles, since the whole cohort generally had fewer contacts with partners from these cities. The data suggest that educational programs among homosexual men attempting to decrease AIDS risk should focus on decreasing the number of partners, receptive anal intercourse, oral exposure to ejaculate and other intimate rectal contact, and sexual contact with men from areas of increased HTLV-III seroprevalence.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3006486     DOI: 10.1016/0002-9343(86)90706-0

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  18 in total

1.  Awareness and use of hepatitis B vaccine among homosexual male clients of a Boston community health center.

Authors:  J McCusker; E M Hill; K H Mayer
Journal:  Public Health Rep       Date:  1990 Jan-Feb       Impact factor: 2.792

Review 2.  Sexual transmission of HIV: routes, efficiency, cofactors and prevention. A survey of the literature.

Authors:  M van der Graaf; R Diepersloot
Journal:  Infection       Date:  1989 Jul-Aug       Impact factor: 3.553

3.  On HIV transmission in homosexual/bisexual men.

Authors:  W M Greenberg
Journal:  Am J Public Health       Date:  1987-12       Impact factor: 9.308

Review 4.  Transmission of human immunodeficiency virus (HIV/HTLV-III/LAV): a review.

Authors:  M van der Graaf; R J Diepersloot
Journal:  Infection       Date:  1986 Sep-Oct       Impact factor: 3.553

5.  Reliability of self-reported sexual behavior risk factors for HIV infection in homosexual men.

Authors:  S P Saltzman; A M Stoddard; J McCusker; M W Moon; K H Mayer
Journal:  Public Health Rep       Date:  1987 Nov-Dec       Impact factor: 2.792

Review 6.  AIDS-related behavioral research and nursing.

Authors:  A Skinner; L Walls; L S Brown
Journal:  J Natl Med Assoc       Date:  1991-07       Impact factor: 1.798

7.  Comparative investigation of Langerhans' cells and potential receptors for HIV in oral, genitourinary and rectal epithelia.

Authors:  L A Hussain; T Lehner
Journal:  Immunology       Date:  1995-07       Impact factor: 7.397

8.  T- and B-cell functions and epitope expression in nonhuman primates immunized with simian immunodeficiency virus antigen by the rectal route.

Authors:  T Lehner; R Brookes; C Panagiotidi; L Tao; L S Klavinskis; J Walker; P Walker; R Ward; L Hussain; J H Gearing
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

9.  Unprotected anal intercourse, risk reduction behaviours, and subsequent HIV infection in a cohort of homosexual men.

Authors:  Fengyi Jin; June Crawford; Garrett P Prestage; Iryna Zablotska; John Imrie; Susan C Kippax; John M Kaldor; Andrew E Grulich
Journal:  AIDS       Date:  2009-01-14       Impact factor: 4.177

Review 10.  The oral mucosa immune environment and oral transmission of HIV/SIV.

Authors:  Lianna F Wood; Ann Chahroudi; Hui-Ling Chen; Heather B Jaspan; Donald L Sodora
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.